EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2019
CVR: 32770487
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,813,678 and a net result of DKK -8,611,095 compared with DKK -9,751,775 the year before. That is an increase of 451.7% compared with the year before. Equity in the 2019 report amounted to DKK -3,684,068. The company had 15 employees in the financial year.
- Gross Profit
- DKK 2,813,678
- Profit/Loss
- DKK -8,611,095
- Equity
- DKK -3,684,068
- Total Assets
- DKK 7,782,167
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.8M | -8.6M | -3.7M | 15 |
| 2018 | - | 510K | -9.8M | -14.3M | 15 |
| 2017 | - | 2.5M | -5.1M | -4.6M | 11 |
| 2016 | - | -494K | -7.1M | 551K | 9 |
| 2015 | - | -2.2M | -6.7M | -4.9M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 20, 2019, Bent Ulrich Frandsen is registered as adm. dir. of EXPRES2ION BIOTECHNOLOGIES ApS.
As of December 20, 2019, Steen Søren Klysner has stepped down as adm. dir. of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2018. Gross profit came to DKK 510,008, and the net result was DKK -9,751,775.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.